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The prevalence of allergies and asthma has dramatically increased in 
developed countries over the last decades, and the incidence rates 
continue to increase especially in low- and middle- income coun-
tries.1 It has been suggested that environmental factors, such as an 
increased exposure to air pollutants and tobacco smoke,2 but also an 
overly sanitary lifestyle, with decreased exposure to parasites, may 
play an important role in the increased prevalence of asthma.
The protective effect of parasitic infections against aller-
gic asthma has been introduced as one of many elements in the 
so- called “old friends hypothesis”.3-6 The relationship between 
helminths and asthma is complex, with factors such as worm spe-
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Chronic helminth infection with Schistosoma (S.) mansoni protects against allergic air-
way	inflammation	(AAI)	in	mice	and	is	associated	with	reduced	Th2	responses	to	in-
haled allergens in humans, despite the presence of schistosome- specific Th2 
immunity.	Schistosome	eggs	strongly	induce	type	2	immunity	and	allow	to	study	the	
dynamics of Th2 versus regulatory responses in the absence of worms. Treatment 
with isolated S. mansoni	eggs	by	i.p.	injection	prior	to	induction	of	AAI	to	ovalbumin	
(OVA)/alum	led	to	significantly	reduced	AAI	as	assessed	by	less	BAL	and	lung	eosino-
philia,	 less	cellular	 influx	 into	 lung	tissue,	 less	OVA-	specific	Th2	cytokines	 in	 lungs	
and lung- draining mediastinal lymph nodes and less circulating allergen- specific IgG1 
and	IgE	antibodies.	While	OVA-	specific	Th2	responses	were	inhibited,	treatment	in-
duced a strong systemic Th2 response to the eggs. The protective effect of S. man-
soni eggs was unaltered in μMT	mice	lacking	mature	(B2)	B	cells	and	unaffected	by	
Treg cell depletion using anti- CD25 blocking antibodies during egg treatment and 
allergic	sensitization.	Notably,	prophylactic	egg	treatment	resulted	in	a	reduced	in-
flux of pro- inflammatory, monocyte- derived dendritic cells into lung tissue of allergic 
mice	following	challenge.	Altogether,	S. mansoni eggs can protect against the devel-
opment	of	AAI,	despite	strong	egg-	specific	Th2	responses.
K E Y W O R D S
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genetics at interplay,7 and a causal link in humans has yet to be 
demonstrated.	 Acute	 or	 light	 helminth	 infections	 seem	 to	 pro-
mote	 allergic	 sensitization	 and	 allergic	 symptoms,	 while	 chronic	
helminth infections are more often associated with protection.7,8 
This may also explain why deworming at population level has been 
shown to result in enhanced skin- prick test positivity or rates of 
eczema	in	some	cases,	while	having	no	effect	 in	others.8	A	 large	
body of epidemiological and experimental studies has shown that, 
despite heterogeneity in the results, especially hookworm infec-
tions	 have	 been	 consistently	 found	 to	 reduce	 allergic	 sensitiza-
tion.9,10 Schistosoma ssp. has also been reported to be protective 
against	allergic	sensitization	in	humans.9,11
Schistosoma ssp. infections consist of an acute phase domi-
nated by a strong Th2 response to the eggs and a chronic phase 
with a diminished Th2 response and increased activity of regu-
latory immune cells.12 To distinguish between egg- induced and 
worm-	induced	 protection	 from	 AAI,	 experimental	 infections	
with mixed sex or male Schistosoma worms were performed.13-19 
However, these reports revealed conflicting results, as some indi-
cated	a	reduction	in	AAI	in	the	presence	of	egg-	producing	infec-
tions,14,16,18,19 whereas others showed a reduction in the absence 
of eggs.13,17	 In	addition,	some	studies	show	protection	from	AAI	
during	 the	acute	 (5-	11	weeks),17,19 and others during the chronic 
(12-	16	weeks)14,18 phase of infection, which elicit characteristi-
cally different immune responses.
From an immunological perspective, the conundrum that Th2- 
inducing helminth infections can dampen symptoms linked to aller-
gic Th2 responses as observed in humans and mouse models7,8 is 
still subject to discussion. Often, the immunomodulatory activity of 
helminths is associated with the induction of a regulatory network. 
In mouse models, the rodent nematodes Heligmosomoides polygyrus 
and Nippostrongylus brasiliensis revealed important insights into the 
role	of	regulatory	T	(Treg)20	and	B	(Breg)21 cells as well as the reg-
ulatory	cytokine	IL-	1022,23	in	protection	against	AAI.	Treg	and	Breg	
cells	as	well	as	IL-	10	have	also	been	described	to	mediate	protection	
induced by S. mansoni infections.14,16-19 However, data showing that 
the acute phase S. mansoni infections and/or the presence of eggs 
are important for protection suggest that the induction of a regu-
latory network is not the sole determinant of immunomodulation.
To further explore the dynamics and interplay between Th2 
responses and regulatory responses in the protective effect of 
S. mansoni	 infections	against	AAI,	we	used	isolated	eggs	instead	of	
a	 full	 natural	 infection.	We	 show	 that	 eggs	 are	 equally	 protective	
as a natural S. mansoni infection in a prophylactic setting, despite 
the induction of a strong egg- specific Th2 response. Egg treatment 
did not lead to Treg cell expansion or enhanced activity markers 
following allergen challenge, and the observed protection was in-
dependent of both Treg cells and B cells. Instead, S. mansoni egg- 
induced protection was associated with a reduced pulmonary influx 
of	pro-	inflammatory	monocyte-	derived	dendritic	cells	(moDCs).	This	
study shows that, although inducing egg- specific Th2 responses, 
S. mansoni	eggs	can	protect	from	AAI,	closely	resembling	the	human	
situation.








(EU	 directive	 no.	 86/609/EEC	 regarding	 the	 Protection	 of	 Animals	
used	 for	 Experimental	 and	 Other	 Scientific	 Purposes).	 B6.129S2-	
Ighmtm1Cgn/J	 (μMT)	 mice	 (C57BL/6	 background)	 were	 kindly	 pro-
vided	 by	 B.	 Lambrecht,	 Ghent	 University	 (Belgium),	 and	 originally	
purchased	from	Jackson	Laboratory	(Bar	Harbor,	USA).
2.2 | Preparation of Schistosoma mansoni eggs
Eggs	were	isolated	from	trypsinized	livers	of	hamsters	infected	for	
50 days with a Puerto Rican strain of S. mansoni, washed with RPMI 
medium	 containing	 300U/mL	 penicillin,	 300	μg/mL	 streptomycin	
(both	 Sigma-	Aldrich,	 St.	 Louis,	MO,	 USA)	 and	 500	μg/mL	 ampho-
tericin	B	(Thermo	Fisher	Scientific,	Waltham,	MA,	USA)	and	frozen	at	
−80°C	until	use.	To	investigate	whether	freeze-	thawed	eggs	still	re-
lease a comparable protein content to that of freshly cultured eggs, 
excretory-	secretory	 product	 (eggES)	 of	 freeze-	thawed	 and	 fresh	
eggs was compared by silver staining after 48 hours of egg culture.
2.3 | Allergic airway inflammation model, egg 
















EDTA	 (Invitrogen),	 followed	 by	 additional	 two	 lavages	 to	 collect	
remaining	cells.	The	1st	BAL	 flush	was	kept	 separate	 for	 cytokine	
analysis in cell- free supernatant, and the cells from all flushes were 
pooled for flow cytometry. Perfused lungs were cut into small 
pieces	and	digested	using	collagenase	 III	 (100	U/mL;	Worthington,	
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Lakewood,	 NJ,	 USA)	 and	 DNase	 (2000	U/mL;	 Sigma-	Aldrich)	 for	
1	hour	at	37°C.	Digested	 lungs	were	homogenized	 through	70	μm 
cell	strainers	(BD	Biosciences,	Franklin	Lakes,	NJ,	USA)	and	remain-
ing red blood cells lysed. In some cases, one side of the lung was 
tied off with surgical suture and removed, and the other side inflated 
with	 and	 collected	 into	 3.9%	 PFA/PBS.	 Mediastinal	 lymph	 nodes	
and	spleens	were	homogenized	through	70-	μm filters, and spleens 
were subjected to red blood cell lysis. Blood for assessment of Treg 
cells was collected from the tail vein 6 days after the first injection 
of anti- CD25 or control antibody and red blood cells were lysed. For 












kit	 (Thermo	 Scientific)	 and	 fluorescently	 labelled	 antibodies	 against	
CD3	 (17A2),	 CD11b	 (M1/70),	 CD11c	 (HL3),	 CD19	 (MB19-	1),	 CD64	






Lungs	 were	 collected	 into	 3.9%	 PFA/PBS	 and	 the	 tissue	 trans-
ferred	 into	 70%	 ethanol	 after	 1-	2	days.	 Lungs	 were	 then	 embed-




on a scale 0- 4 by two blinded, independent investigators.
2.7 | ELISA and CBA
OVA-	 and	 SEA-	specific	 IgG1	 and	 IgE	 antibodies	 were	 measured	




antibodies	 against	 IgG1	 and	 IgE	 (BD	Biosciences)	 and	 horseradish	
peroxidase-	conjugated	 streptavidin	 (BD	Biosciences).	Optical	 den-
sities were measured after addition of TMB peroxidase substrate 







Statistical	 analysis	 was	 performed	 with	 GraphPad	 Prism	 (version	
7.02)	 using	 unpaired	 t	 test	 for	 comparison	 of	 2	 groups,	 one-	way	
ANOVA	 for	 comparison	 of	 more	 than	 two	 groups	 and	 two-	way	
ANOVA	for	comparison	of	more	than	two	groups	while	correcting	
for	a	batch	effect	between	different	experiments.	All	data	are	pre-
sented	as	mean	±	SE	of	the	mean	(SEM).	P- values < 0.05 were con-
sidered statistically significant.
3  | RESULTS
3.1 | Schistosoma mansoni eggs protect against 
OVA/alum- induced AAI
We	 and	 others	 have	 previously	 reported	 that	 chronic,	 but	 not	
acute, mixed infection with S. mansoni, which most closely re-
sembles the natural situation in humans, protects mice from al-
lergic airway inflammation.14,16,18,19	 A	 plausible	 explanation	 for	
the differential effect of acute and chronic infection might be the 
changing balance between Th2 and regulatory responses. To fur-
ther explore the dynamics and interplay between Th2 and regu-
latory responses in helminth infections, we first tested whether 
S. mansoni	 liver-	derived	 eggs	 can	 confer	 protection	 from	 AAI	 in	
the absence of worms. These eggs were isolated from livers of 
infected	hamsters	and	frozen	prior	to	use.	We	have	confirmed	that	
the	excretory-	secretory	product	 (eggES)	 of	 these	 freeze-	thawed	
eggs is similar to that of freshly isolated, mature liver eggs (Figure 
S1A).	Mice	were	treated	twice	with	5	x	103 eggs by i.p. injection 
prior	to	allergic	sensitization	with	OVA	emulsified	in	alum	adjuvant	
(Figure	1A).	 This	 treatment	 resulted	 in	 a	 profound	 suppression	
of overall cellularity and eosinophilia both in the bronchoalveo-
lar	 lavage	 (BAL)	 fluid	 (Figure	1	B)	and	 in	 lung	tissue	 (Figure	S1B),	
accompanied by a reduction in various other leucocyte popula-
tions	(Figure	1C).	The	reduction	in	AAI	in	treated	mice	was	also	re-




production	 in	 BAL	 fluid,	 as	well	 as	 local	 recall	 responses	 to	 the	
allergen	by	 restimulation	of	medLN	with	OVA.	 In	both	BAL	 fluid	
and	OVA-	restimulated	medLN	cell	cultures,	the	production	of	al-
lergic	Th2	cytokines	IL-	5	and	IL-	13	was	greatly	increased	in	allergic	
mice,	 but	blocked	upon	egg	 treatment	 (Figure	1F,G).	 IL-	10,	while	
not	 detectable	 in	 BAL	 fluid,	 followed	 the	 same	 pattern	 as	 IL-	5	
and	 IL-	13	 in	 OVA-	restimulated	 medLN	 cell	 cultures	 (Figure	1G).	
Additionally,	IFN-	γ	could	hardly	be	detected	in	both	BAL	fluid	and	
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OVA-	restimulated	medLN	cell	cultures	(Figure	1F,G).	Collectively,	
these data show that S. mansoni egg administration prior to aller-
gic	sensitization	inhibits	the	development	of	OVA-	induced	AAI.
3.2 | Protection occurs despite the induction of an 
egg- specific Th2 response
Human and animal hosts are known to mount a strong type 2 im-
mune responses to egg deposition in live infections. To determine 
whether egg treatment induced a systemic, antigen- specific cy-
tokine response in our model, we restimulated spleen cell cultures 
with	 soluble	egg	antigens	 (SEA).	 SEA	 restimulation	profoundly	 in-
creased	 the	 production	 of	 IL-	5,	 IL-	10	 and	 IL-	13,	 but	 not	 IFN-	γ, in 
mice that had received isolated eggs compared to naïve or allergic, 
untreated	mice	(Figure	2A).	In	the	medLN,	similar	cytokine	profiles	
were	observed	following	SEA	restimulation	(Figure	S2).	Furthermore,	
OVA-	restimulated	 spleen	 cell	 cultures	 induced	 a	 strong	 Th2	 cy-
tokine	production	in	the	allergic	group	(Figure	2B).	Strikingly,	these	




treatment induces a fully developed Th2 response to egg antigens in 
the	absence	of	an	allergic	Th2	response	to	OVA.
3.3 | Egg- induced protection against AAI is 
independent of Treg cells
Schistosoma mansoni infection16,19 and antigens25,26 have been de-
scribed to induce Treg cells in mice and humans. Therefore, we ad-
dressed whether egg treatment enhanced the number or activation 
state of Treg cells following allergen challenge in our model. The 










comparisons	test	(C-	F)	and	are	indicated	with	*P < 0.05, **P < 0.01, ***P < 0.001




determined	by	one-	way	ANOVA	following	Dunnett’s	multiple	comparisons	test	and	are	indicated	with	*P < 0.05, ***P < 0.001







Dunnett’s	multiple	comparisons	test	as	indicated	with	*P < 0.05, **P < 0.01, ***P < 0.001 or by unpaired t test as indicated by #P < 0.05
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frequency	and	number	of	Treg	cells	were	significantly	 increased	 in	
the	BAL	fluid	of	allergic	mice,	but	remained	at	baseline	in	mice	treated	
with	 eggs	 (Figure	3A).	While	 the	 frequency	of	 Treg	 cells	 remained	
unchanged	in	the	medLNs,	total	numbers	increased	in	allergic	mice	




ther dissect the role of Treg cells in egg- mediated suppression, we 






ies against anti- β- galactosidase (anti- βGAL)	(Figure	3F),	as	well	as	re-
duced	numbers	of	neutrophils	(Figure	3G).	In	contrast,	in	egg-	treated	
mice, Treg cell depletion did seem to affect the number of DCs, T 
cells	and	B	cells	in	the	BAL	fluid	at	least	to	some	extent,	as	their	num-
bers were increased and not significantly different anymore between 
allergic	 controls	 and	 egg-	treated	mice	 (Figure	3G).	We	 observed	 a	
similar	trend	in	the	secretion	of	type	2	cytokines	IL-	5	and	IL-	13	in	BAL	
fluid following Treg cell depletion, which were restored compared to 
those	in	allergic	control	mice	(Figure	3H).	These	data	may	suggest	a	
selective effect on the lung T- cell compartment following anti- CD25 
treatment,	resulting	in	enhanced	T-	cell	activation.	Although	there	is	a	
general trend towards increased airway inflammation following anti-
 CD25 treatment in both allergic control and egg- treated mice, this 
effect seems to be more pronounced in the egg- treated group with 
respect	 to	 the	 lung	 T-	cell	 compartment.	 Anti-	CD25	 treatment	 did	
however not restore eosinophilic inflammation in egg- treated mice. 
Collectively, these data suggest that depletion of Treg cells does not 
have	a	major	influence	on	inhibition	of	AAI	by	egg	treatment	and	thus	
cannot	explain	egg-	induced	protection	against	AAI.
3.4 | Mature B cells are not crucial for egg- induced 
protection against AAI







indicated with *P < 0.05, **P < 0.01, ***P < 0.001 or by unpaired t test as indicated by #P < 0.05, ##P < 0.01
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functions ranging from antibody production, formation of mem-
ory and antigen presentation to the production of pro- and anti- 
inflammatory cytokines. The production of regulatory cytokines 
such	as	IL-	10	and	the	production	of	inhibitory	immunoglobulins	are	
the	widely	 recognized	 regulatory	 functions	 exerted	 by	 B	 cells.27 
Here, we used μMT	mice,	which	lack	mature	(B2)	B	cells,28 to test 
whether	B	cells	are	required	for	the	protective	effect	observed	on	





BAL	 neutrophils,	 DCs	 and	 T	 cells	 (Figure	4B).	 Additionally,	while	
B	 cells	 sharply	 increased	 in	 WT	 mice	 and	 decreased	 with	 egg	
treatment, the number of B cells was expectedly low in μMT mice 




cell	 cultures	 from	WT	mice	was	highly	elevated	 in	AAI	mice	and	
significantly	reduced	after	egg	treatment	(Figure	5C).	Allergic	μMT 
mice	produced	significantly	less	IL-	5,	IL-	10	and	IL-	13	compared	to	
their	WT	 counterparts	 (Figure	4C),	 like	 recently	 also	 shown	 in	 a	
house dust mite model of asthma.29	 As	 expected,	 OVA-	specific	
IgG1 and IgE antibodies in μMT mice remained at baseline values 
observed	in	naïve	WT	animals	(Figure	4D),	excluding	a	major	role	
of inhibitory antibodies in protection. These data show that B2 B 
cells, while contributing to Th2 cytokine production and the pro-
duction	of	 antigen-	specific	 antibody	 responses,	 are	 not	 required	
for	egg-	mediated	protection	from	AAI.
3.5 | Egg treatment is associated with decreased 
recruitment of moDCs in the lung compartment
Different studies have shown that helminths not only affect T and B 
cells, but also can mediate important effects by acting on DCs.30,31 
Pulmonary DCs play a central role in the immune response to 
allergens.32 Under steady state conditions, CD103+ and CD11b+ 
conventional	DC	(cDC1	and	cDC2,	respectively)	populations	can	be	
distinguished, whereas allergic inflammation triggers a strong influx 
of	 inflammatory,	 monocyte-	derived	 DCs	 (moDCs).33 Both CD11b+ 
cDC2 and moDCs can drive allergic Th2 responses in a model of HDM 
allergy, whereby moDCs were only sufficient in a high- dose HDM 
model	of	AAI.34 moDCs produce various chemokines and present al-
lergen locally in the lung especially in a model of high- dose allergen 
exposure.34	 Next,	 we	 investigated	whether	 prophylactic	 egg	 treat-
ment alters the presence and function of different DC subsets in the 
lung	of	OVA/alum-	allergic	mice.	The	number	of	CD11c+ MHCII+ DCs 
strongly	 increased	 in	 allergic	 compared	 to	 control	mice	 (Figure	5A).	
Interestingly, egg treatment significantly impaired the number of lung 
DCs following challenge, whereas the total number of cells in the 
lung	remained	unaffected	(Figure	5A).	The	reduction	in	number	of	all	
CD11c+ MHCII+ DCs seems to be solely attributable to an abrogated 
expansion of the moDC compartment, as both the numbers of CD11b+ 
cDC2 and CD103+ cDC1s proved to be unaffected by egg treatment 
(Figure	5B).	Monocytes,	which	can	differentiate	into	moDCs	under	in-
flammatory	conditions,	migrate	in	a	CCR2/CCL2-	dependent	manner,	
whereas CD11b+ cDC2 and CD103+ cDC1s do not.34	We	found	the	
concentration	of	CCL2	 in	BAL	 fluid	 to	be	 strikingly	 increased	 in	al-
lergic	mice	and	significantly	reduced	upon	egg	treatment	(Figure	5C),	
providing an indication that the reduced number of moDCs in lung 
tissue	is	the	result	of	reduced	CCL2-	mediated	influx.
4  | DISCUSSION
In	 this	 study,	 we	 sought	 to	 further	 characterize	 the	 potential	 of	
S. mansoni to protect from allergic asthma, despite profound egg- 
specific Th2 responses, by using isolated S. mansoni eggs in a setting 
without	adult	worms.	We	show	that	S. mansoni eggs are capable of 
protecting	against	experimental	AAI,	which	is	 in	line	with	previous	
reports16,35 and in contrast to earlier work postulating that protec-
tion can only be achieved in the absence of female egg- laying worms. 
We	found	 that	protection	 from	AAI	 can	also	be	achieved	by	eggs	
F IGURE  5 Egg	treatment	impairs	the	lung	moDC,	but	not	cDC,	compartment.	A,	Total	number	of	lung	cells,	and	total	number	of	lung	DCs	
(CD11c+ MHCII+),	assessed	by	FACS.	Representative	of	2	experiments,	n	=	4-6.	B,	Total	number	of	moDCs	(CD11c+ MHCII+ CD11b+ CD103− 
CD64+),	CD103+ cDC1 (CD11c+ MHCII+ CD11b− CD103+ CD64−)	and	CD11b+ cDC2s (CD11c+ MHCII+ CD11b+ CD103− CD64−)	in	the	lung,	
assessed	by	FACS	(see	Figure	S5	for	the	gating	strategy).	Representative	of	2	experiments,	n	=	4-6.	C,	Concentration	of	CCL2	in	BAL	fluid	
measured	by	CBA.	Summary	of	2	experiments,	n	=	9-10.	Significant	differences	were	determined	by	one-way	ANOVA	following	Dunnett’s	
multiple comparisons test and as indicated with *P < 0.05, ***P < 0.001
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isolated	 from	 infected	mice	 instead	of	hamsters	 (data	not	 shown),	
excluding confounding factors from contaminations of egg prepara-
tions with traces of hamster tissue. The data on administration of 
isolated eggs and the cellular mechanisms eggs can induce in the 
context of an allergic inflammation is still very limited. This study 
aims to advance the current knowledge as it provides new insight 




mally induced by alum, is completely absent. This is in line with 
earlier observations in chronic S. mansoni infections14 and after 
treatment with excretory- secretory products of T. suis.36 Mangan 
et al describe a “helminth- modified pulmonary Th2 response” in 
S. mansoni	 infection,	 characterized	 by	 elevated	 pulmonary	 IL-	10	
and	IL-	13,	but	reduced	IL-	5.13,37	We	found	the	production	of	OVA-	
specific Th2 cytokines to be reduced upon egg treatment, which 
argues against a putative “modified Th2 response” in our egg treat-
ment model and is similar to what has been described in humans. 
People in schistosome- endemic areas, for which a negative associ-
ation	between	chronic	infection	and	allergic	sensitization	has	been	
shown, often have elevated Th2 responses to the eggs alongside 
reduced allergic symptoms.7,8 However, a recent study on a fishing 
community in Uganda, with a low prevalence of allergy- related dis-
eases, found a positive correlation between S. mansoni- specific Th2 




important for protection by natural infections.14,16-19	We	observed	
that	the	number	of	pulmonary	Treg	cells	was	increased	in	the	BAL	
fluid of allergic mice during the challenge phase, which has similarly 
been reported by others,36,39 but returns to baseline rather than 
continues to rise in treated animals. Following allergen challenge, 
egg- treated mice did not induce Treg cell numbers or enhance the 
expression of regulatory activity markers in the lung compartment 
compared	to	untreated,	allergen-	challenged	mice.	In	addition,	IL-	10	
in	 BAL	 fluid	 of	 egg-	treated	 animals	was	 unchanged	 following	 egg	
treatment. The fact that Treg cells did not exceed the baseline levels 
from naïve control mice combined with the lack of any activity mark-
ers suggests that there is no active suppression by Treg cells during 
the allergen challenge phase. Mice depleted of CD25- expressing 
Treg	cells	during	egg	 treatment	and	allergic	 sensitization	display	a	
similar	degree	of	AAI	 suppression,	despite	 the	 inflammation	being	
generally increased upon Treg depletion. Probably, as a result of a 
dysregulated Treg to effector T- cell balance, this suggests that egg- 
induced Treg cells do not play a decisive role in egg- induced pro-
tection	from	AAI	in	our	hands.	These	findings	seem,	at	least	in	part,	
contrary to a previous report on the putative role of Treg cells in a 
similar model of egg administration.16,19 Discrepancies in the results 




μMT mice with S. mansoni eggs. μMT mice lack mature, conventional 
B2 B cells.28 Most studies report that μMT mice mount an allergic re-
sponse	similar	to	their	WT	counterparts.40-42 In line with these data, 
we also found the allergic response to be unaffected in μMT mice, 
apart from a significant reduction in the allergen- specific Th2 cyto-
kine	production	by	medLN	cells.	This	could	be,	at	least	in	part,	due	
to the amount of allergen used, as we have previously reported an 
important	role	for	B	cells	in	low-	dose	HDM-	induced	AAI.29 Despite 
the	difference	in	OVA-	specific	Th2	responses,	egg	treatment	equally	
protects	from	AAI	both	in	WT	and	μMT mice, indicating that mature 
B	cells	are	not	crucial	for	protection.	While	this	does	not	formally	ex-
clude a role for all Breg cell subsets, which can be present in both the 
B1 and B2 B- cell compartment,43-45 we believe they are unlikely to 
play a major role as we have previously studied the induction of Breg 
cells by S. mansoni	infection,	SEA	and	the	single	egg	molecule	IPSE/
alpha- 1 and predominantly identified Breg cells within the splenic 
marginal	 zone	 (MZ)	 B-	cell	 compartment	 as	well	 as	 the	 pulmonary	
B- cell compartment.46,47 Both MZ B cells, which belong to the B2 
B- cell lineage, and pulmonary B cells are absent in μMT mice and 
thus	unlikely	crucial	for	protection.	Additionally,	μMT mice are also 
unable to mount an allergen- specific antibody response,45 excluding 
a role of inhibitory antibodies in protection.
Dendritic cells play a central role in the induction of adaptive 
immune	 responses	 in	 the	 context	of	AAI.	Both	CD11b+ cDCs and 
moDCs can drive allergic Th2 responses in a model of HDM allergy, 
with moDCs being sufficient in models of high- dose allergen expo-
sure.34 Moreover, Schistosoma infection has been shown to func-
tionally impair myeloid DCs in humans.30 Here, we show that during 
the	challenge	phase	of	OVA/alum-	induced	AAI,	control	mice	depict	
a sharp influx of moDCs, as well as increased numbers of CD103+ 
cDC1 and CD11b+ cDC2s. Interestingly, egg treatment selectively 
affects the lung moDC compartment, whereas both cDC populations 
remained	 unchanged.	 The	 reduced	 concentration	 of	 CCL2	 in	 BAL	
fluid of egg- treated mice suggests that the recruitment of moDCs 
into	 the	 lung	 is	 impaired.	 During	 allergic	 sensitization	 with	 alum-	
supplemented allergen by i.p. injection, inflammatory monocytes are 
recruited to the peritoneal cavity within hours and ingest allergens 
in a uric acid- dependent manner. They migrate to the lung- draining 
medLNs	and	develop	there	into	moDCs	that	contribute	to	the	devel-
opment of a Th2 response.48 It is unclear whether this inflammatory 
monocyte	response	to	allergic	sensitization	in	the	peritoneal	cavity	
was targeted by egg treatment or whether the reduced pulmonary 
moDC	levels	are	the	consequence	of	reduced	inflammation	and	re-
duced	CCL2	 levels.	 Preliminary	 data	 suggest	 that	moDCs	 isolated	
from allergic and egg- treated mice behave similarly, and both have a 
poor	T-	cell	stimulatory	capacity	(data	not	shown).	This	may	suggest	
that	 the	observed	 reduced	number	of	moDCs	 is	 the	 consequence	
rather	than	the	cause	of	reduced	AAI	in	egg-	treated	mice.
To date, a few single, immunomodulatory molecules from hel-
minths	 have	 been	 identified,	 including	 ES-	62	 and	 Av17	 from	 the	
filarial nematode Acanthocheilonema viteae,49,50	 AIP-	2	 from	 hook-
worms51	 as	well	 as	HpARI52 and Hp- TGM53 from H. polygyrus. For 
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Schistosoma eggs, no immunomodulatory molecule has been charac-
terized	in	a	similar	manner	to	date.	The	S. mansoni egg secretome has 
been described to contain 188 proteins.54	 Some	of	 these	proteins	
have been shown to fulfil distinct functions,47,55 whereas the role of 
others	 remains	 poorly	 characterized.56,57 Cardoso et al26 describe 
three	single	molecules,	Sm22.6,	PIII	and	Sm29,	to	all	suppress	allergic	
airway inflammation, all of which are not present in the egg stage of 
the life cycle. The only description of a Schistosoma ssp. egg- derived 
molecule	inhibiting	AAI	is	the	S. japonicum	molecule	SjP40,	which	in-
duces	IFN-	γ production.58	As	we	find	low	levels	of	IFN-	γ produced 
in response to the eggs, we do not expect that the S. mansoni homo-
logue	SmP40	mediates	protection	in	our	study.	It	will	be	the	subject	
of future studies to identify single molecules secreted from S. man-
soni eggs capable of modulating allergic asthma and further defining 
the immunological mechanism of suppression. To date, most studies 
have focussed on identifying single, egg- derived antigens as vaccine 
candidates rather than immunomodulatory agents.59 This study 
shows that, although eggs are inducers of a strong Th2 response, 
it is worthwhile to study the immunomodulatory capacities of egg- 
derived antigens.
In summary, here the presented data show that the suppressive 
effect of S. mansoni infection on allergic asthma can be replicated 
by isolated eggs. This effect occurs despite a strong Th2 response 
to the eggs itself and is likely independent of Treg and B cells during 
allergen challenge. Egg treatment strongly and selectively affects 
the lung moDC compartment. Understanding the complex interac-
tions	early	during	allergic	sensitization—and	how	helminths	interfere	
there—is	critical	for	the	development	of	preventative	strategies	for	
allergies and allergy- related diseases.
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